Vasoconstrictor Topical Composition for Dark Circle Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for dark circles under the eyes, such as hydroquinone-based creams and chemical peels, often have side effects and are not suitable for long-term use, and existing cosmetic products are not highly effective in addressing the multifactorial causes of this condition.
Innovation Solution
A topical composition containing ophthalmic vasoconstrictors or their inorganic or organic salts, combined with other agents, is developed for safe and effective skin lightening, particularly for the face and under-eye area, which can be used over extended periods without significant side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If hydroquinone-based creams are used to treat dark circles, then skin lightening effect is improved, but side effects increase and long-term usability decreases
Solution Approach 1:
The patent changes the active ingredient parameter from hydroquinone to vasoconstrictors (such as naphazoline, tetrahydrozoline, or phenylephrine), fundamentally altering the mechanism of action from melanin inhibition to vascular constriction. This parameter change maintains skin lightening effectiveness while eliminating the harmful side effects associated with hydroquinone, enabling safe long-term use.
2Reliability
If chemical peels are used to treat dark circles, then skin lightening effect is improved, but safety and long-term usability deteriorate
Solution Approach 1:
The patent replaces chemical peeling agents with vasoconstrictor-based topicals, changing the treatment mechanism from chemical exfoliation to vascular constriction. This parameter change achieves skin lightening through a safer mechanism that does not compromise skin integrity or cause the harmful effects associated with chemical peels, allowing for sustained long-term use.
3Ease of operation
If existing cosmetic products are used, then ease of operation is maintained, but effectiveness in addressing multifactorial causes decreases
Solution Approach 1:
The patent formulates a multi-functional cosmetic product that simultaneously addresses multiple causes of dark circles: vasoconstrictors for vascular congestion, antioxidants for pigmentation, and anti-inflammatory agents for irritated tissue. This universal formulation maintains the ease of operation of simple topical application while significantly improving effectiveness by targeting all four main categories of dark circle causes in a single product.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively lightens darkened skin and improves the appearance of dark circles by reducing vascular and hyperpigmentation issues, with visible results within 6-8 hours and sustained improvements over several weeks of use.
Implementation Method 1
compositions comprising ophthalmic vasoconstrictors and/or their inorganic or organic salts
Data Source
AI summary
A cosmetically acceptable product for application to human skin is disclosed. The novel compositions are particularly suited for skin lightening and for diminishing the appearance of “dark circles” under the eyes. The compositions include any of several vasoconstrictors in a carrier with optionally added skin compatible ingredients.